EP Patent

EP3250567A1 — 4h-pyrrolo[3,2-c]pyridin-4-one derivatives

Assigned to Bayer Pharma AG · Expires 2017-12-06 · 8y expired

What this patent protects

Compounds of formula (I), processes for their production and their use as pharmaceuticals.

USPTO Abstract

Compounds of formula (I), processes for their production and their use as pharmaceuticals.

Drugs covered by this patent

Patent Metadata

Patent number
EP3250567A1
Jurisdiction
EP
Classification
—
Expires
2017-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.